Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL198P is a human pseudogene that is part of a widespread family of truncated 7SL RNA-derived elements scattered throughout the genome[4][5]. Pseudogenes like RN7SL198P are formed from reverse transcription and integration of RNA molecules and do not encode functional RNA or proteins. Unlike the functional 7SL RNA, which plays a crucial role in the signal recognition particle for protein targeting and translocation[1][2][3], RN7SL198P does not produce a functional molecule and has no established biological or therapeutic significance[4][5]. RN7SL198P is not a receptor, transporter, enzyme, or protein—nor does it fulfill a canonical molecular function. It is a non-coding pseudogene without direct biological activity or disease relevance. The only functional relevance comes from its ancestry: other functional 7SL RNA genes mediate essential protein targeting via the SRP complex, but pseudogenes like RN7SL198P do not participate in these processes[4][5]. If you seek a functional molecule or receptor from the signal recognition particle pathway, focus on the genuine 7SL RNA (RN7SL1), not pseudogenes like RN7SL198P[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 198, pseudogene (RN7SL198P).